These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26410743)

  • 61. Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations.
    Carbunaru S; Eisinger RS; Ramirez-Zamora A; Bassan D; Cervantes-Arriaga A; Rodriguez-Violante M; Martinez-Ramirez D
    Brain Behav; 2018 Mar; 8(3):e00904. PubMed ID: 29541533
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A search for cortical correlates of trait impulsivity in Parkinson´s disease.
    Kubera KM; Schmitgen MM; Nagel S; Hess K; Herweh C; Hirjak D; Sambataro F; Wolf RC
    Behav Brain Res; 2019 Sep; 369():111911. PubMed ID: 30991086
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
    Price CC; Tanner J; Nguyen PT; Schwab NA; Mitchell S; Slonena E; Brumback B; Okun MS; Mareci TH; Bowers D
    PLoS One; 2016; 11(1):e0147332. PubMed ID: 26784744
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.
    Lewis MM; Du G; Lee EY; Nasralah Z; Sterling NW; Zhang L; Wagner D; Kong L; Tröster AI; Styner M; Eslinger PJ; Mailman RB; Huang X
    J Neurol; 2016 Jan; 263(1):68-75. PubMed ID: 26486354
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Delay discounting of reward and caudate nucleus volume in individuals with α-synuclein gene duplication before and after the development of Parkinson's disease.
    Szamosi A; Nagy H; Kéri S
    Neurodegener Dis; 2013; 11(2):72-8. PubMed ID: 23038403
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson's Disease.
    Waskowiak P; Koppelmans V; Ruitenberg MFL
    J Parkinsons Dis; 2022; 12(2):689-697. PubMed ID: 34897102
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between motor learning and gambling propensity in Parkinson's disease.
    Ueda N; Higashiyama Y; Saito A; Kimura K; Nakae Y; Endo M; Joki H; Kugimoto C; Kishida H; Doi H; Takeuchi H; Koyano S; Tanaka F
    J Clin Exp Neuropsychol; 2022 Feb; 44(1):50-61. PubMed ID: 35658796
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.
    Lopez AM; Weintraub D; Claassen DO
    Semin Neurol; 2017 Apr; 37(2):186-192. PubMed ID: 28511259
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease.
    Gerrits NJ; van Loenhoud AC; van den Berg SF; Berendse HW; Foncke EM; Klein M; Stoffers D; van der Werf YD; van den Heuvel OA
    PLoS One; 2016; 11(2):e0148852. PubMed ID: 26919667
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impulse control disorders in Parkinson's disease: recent advances.
    Voon V; Mehta AR; Hallett M
    Curr Opin Neurol; 2011 Aug; 24(4):324-30. PubMed ID: 21725242
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks.
    Vriend C
    Cell Tissue Res; 2018 Jul; 373(1):327-336. PubMed ID: 29383446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management.
    Wu K; Politis M; Piccini P
    Postgrad Med J; 2009 Nov; 85(1009):590-6. PubMed ID: 19892894
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuropsychiatric symptoms in Parkinson's disease: fronto-striatal atrophy contributions.
    O'Callaghan C; Shine JM; Lewis SJ; Hornberger M
    Parkinsonism Relat Disord; 2014 Aug; 20(8):867-72. PubMed ID: 24866458
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A clinical and genetic study of impulsive-compulsive disorders in patients with Parkinson's disease].
    Shipilova NN; Titova NV; Kokaeva ZG; Fedosova AS; Klimov EA; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):4-9. PubMed ID: 30499488
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores.
    Faouzi J; Couvy-Duchesne B; Bekadar S; Colliot O; Corvol JC
    Parkinsonism Relat Disord; 2021 May; 86():74-77. PubMed ID: 33872999
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impulse control and related behaviors in Parkinson's disease with dementia.
    Martinez-Martin P; Wan YM; Ray Chaudhuri K; Schrag AE; Weintraub D
    Eur J Neurol; 2020 Jun; 27(6):944-950. PubMed ID: 32048392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
    Gan C; Cao X; Sun H; Ye S; Shi J; Shan A; Gao M; Wan C; Zhang K; Yuan Y
    Neurobiol Dis; 2024 Aug; 198():106560. PubMed ID: 38852751
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impulse control disorders in Parkinson's disease are associated with dysfunction in stimulus valuation but not action valuation.
    Piray P; Zeighami Y; Bahrami F; Eissa AM; Hewedi DH; Moustafa AA
    J Neurosci; 2014 Jun; 34(23):7814-24. PubMed ID: 24899705
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease.
    Kim A; Kim YE; Kim HJ; Yun JY; Yang HJ; Lee WW; Shin CW; Park H; Jung YJ; Kim A; Ehm G; Kim Y; Jang M; Jeon B
    Parkinsonism Relat Disord; 2018 Nov; 56():3-8. PubMed ID: 30054182
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Management of Impulse Control Disorders with Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.
    Amstutz D; Paschen S; Lachenmayer ML; Maradan-Gachet ME; Deuschl G; Krack P; Debove I
    CNS Neurol Disord Drug Targets; 2020; 19(8):611-617. PubMed ID: 32691720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.